Liangpin Li, Liyun Yuan, Xueyan Zhou, Xia Hua & Xiaoyong Yuan. (2023) Bibliometric analysis of the Vogt‒Koyanagi‒Harada disease literature. International Ophthalmology.
Crossref
Zhenyu Zhong, Lingyu Dai, Qiuying Wu, Yu Gao, Yanlin Pu, Guannan Su, Xiaorong Lu, Fuxiang Zhang, Chong Tang, Yao Wang, Chunjiang Zhou & Peizeng Yang. (2023) A randomized non-inferiority trial of therapeutic strategy with immunosuppressants versus biologics for Vogt-Koyanagi-Harada disease. Nature Communications 14:1.
Crossref
Najiha Rahman, Jose Carlo M Artiaga, Konstantinos Bouras, Joshua Luis, Angela Rees & Mark Westcott. (2023) Immunosuppressive therapy for Vogt-Koyanagi-Harada disease: a retrospective study and review of literature. Journal of Ophthalmic Inflammation and Infection 13:1.
Crossref
Dominique Prétot, Katrin Marie Engesser, Torsten Schlote & Maria Della Volpe. (2023) When Your Patient Needs New Glasses Every Day. Klinische Monatsblätter für Augenheilkunde 240:04, pages 566-568.
Crossref
Cristhian A. Urzua, Carl P. HerbortJrJr, Masaru Takeuchi, Ariel Schlaen, Luz E. Concha-del-Rio, Yoshihiko Usui, Loreto Cuitino & Ioannis Papasavvas. (2022) Vogt-Koyanagi-Harada disease: the step-by-step approach to a better understanding of clinicopathology, immunopathology, diagnosis, and management: a brief review. Journal of Ophthalmic Inflammation and Infection 12:1.
Crossref
Ruyi Han, Gezhi Xu & Xinyi Ding. (2022) COVID-19 Vaccine-Related Vogt–Koyanagi–Harada Disease Complicated by Central Serous Chorioretinopathy during Treatment Course: Case Report and Literature Review. Vaccines 10:11, pages 1792.
Crossref
Massimo Accorinti, Maria Carmela Saturno, Ludovico Iannetti, Priscilla Manni, Davide Mastromarino & Maria Pia Pirraglia. (2022) Treatment and Prognosis of Vogt–Koyanagi–Harada Disease: Real-Life Experience in Long-Term Follow-Up. Journal of Clinical Medicine 11:13, pages 3632.
Crossref
Wen Shi, Jinguo Ye, Zhuoxing Shi, Caineng Pan, Qikai Zhang, Yuheng Lin, Yuanting Luo, Wenru Su, Yingfeng Zheng & Yizhi Liu. (2022) Chromatin accessibility analysis reveals regulatory dynamics and therapeutic relevance of Vogt-Koyanagi-Harada disease. Communications Biology 5:1.
Crossref
Pedro Arriola-Villalobos, Aina Moll-Udina, Mario Carrasco-López-Brea, Cristina Sacristan, Maria Jose Capella, Diana Peiteado, Ana Garrote-Llordén, Mara Albert Fort, Margarita Jódar Márquez, Juan Jacobo Gonzalez Guijarro, Rosalia Demetrio-Pablo, Juan Luis Sánchez Sevilla, Ester Carreño, Julio González-López, Lucia Miguel-Escuder, Carlos Cuadros, David Díaz-Valle, Alfredo Adan, José M Benítez del Castillo, Alejandro Fonollosa, Miguel Cordero, Lucia Martínez Costa & Ricardo Blanco-Alonso. (2021) Vogt-Koyanagi-Harada disease in Spain. European Journal of Ophthalmology 32:3, pages 1547-1554.
Crossref
Ioannis Papasavvas, Ilknur Tugal-Tutkun & Carl P. HerbortJr.Jr.. (2022) Mechanisms, Pathophysiology and Current Immunomodulatory/Immunosuppressive Therapy of Non-Infectious and/or Immune-Mediated Choroiditis. Pharmaceuticals 15:4, pages 398.
Crossref
Takashi Ono, Hiroshi Goto, Tsutomu Sakai, Fumihiko Nitta, Nobuhisa Mizuki, Hiroshi Takase, Yutaka Kaneko, Junko Hori, Satoko Nakano, Nobuhisa Nao-I, Nobuyuki Ohguro, Kazunori Miyata, Makoto Tomita, Manabu Mochizuki, Manabu Mochizuki, Takashi Ono, Takashi Komizo, Kazurori Miyata, Hiroshi Goto, Akihiko Umazume, Yoshihiko Usui, Tsutomu Sakai, Hideo Kohno, Ranko Aoyagi, Fumihiko Nitta, Kazuichi Maruyama, Nobuhisa Mizuki, Etsuko Shibuya, Yasutsugu Ida, Hiroshi Takase, Shintaro Horie, Mitsunao Ide, Yuko Iwasaki, Koju Kamoi, Yukiko Terada, Yutaka Kaneko, Junko Hori, Tomoko Yui, Ayaka Takeda, Satoko Nakano, Nobuhisa Nao-I, Nobuyuki Ohguro & Makoto Tomita. (2021) Comparison of combination therapy of prednisolone and cyclosporine with corticosteroid pulse therapy in Vogt–Koyanagi–Harada disease. Japanese Journal of Ophthalmology 66:2, pages 119-129.
Crossref
Fuxiang Yuan, Yu Zhang & Xiaoran Yan. (2020) Bilateral acute angle closure glaucoma as an initial presentation of Vogt-Koyanagi-Harada syndrome: A clinical case report. European Journal of Ophthalmology 32:1, pages NP230-NP234.
Crossref
Jessy Choi, Alexander Bossuyt, Nicole Shu-Wen Chan & Grace Wu. 2022. Pediatric Retinal Diseases. Pediatric Retinal Diseases
57
85
.
Ahmed M. Abu El-Asrar, Jo Van Damme, Sofie Struyf & Ghislain Opdenakker. (2021) New Perspectives on the Immunopathogenesis and Treatment of Uveitis Associated With Vogt-Koyanagi-Harada Disease. Frontiers in Medicine 8.
Crossref
M. Aguilar-González, P. Martínez-López-Corell, E. Marín-Payá, M. Díaz-Llopis, R. Gallego-Pinazo & M. Andreu-Fenoll. (2021) Vogt-Koyanagi-Harada: treatment of recurrence after administration of 3 intravenous bolus of 1 g of corticosteroids and mycophenolate mofetil. Archivos de la Sociedad Española de Oftalmología (English Edition) 96:11, pages 593-597.
Crossref
M. Aguilar-González, P. Martínez-López-Corell, E. Marín-Payá, M. Díaz-Llopis, R. Gallego-Pinazo & M. Andreu-Fenoll. (2021) Vogt-Koyanagi-Harada: tratamiento de la recurrencia tras la administración de 3 bolos intravenosos de 1 g de corticoides y micofenolato de mofetilo. Archivos de la Sociedad Española de Oftalmología 96:11, pages 593-597.
Crossref
. (2021) Classification Criteria for Vogt-Koyanagi-Harada Disease. American Journal of Ophthalmology 228, pages 205-211.
Crossref
Pranav Shrestha, Sadhana Sharma & Ranju Kharel. (2021) Vogt-Koyanagi-Harada Disease: A Case Series in a Tertiary Eye Center. Case Reports in Ophthalmological Medicine 2021, pages 1-5.
Crossref
K. Diallo, S. Revuz, G. Clavel-Refregiers, T. Sené, C. Titah, M. Gerfaud-Valentin, P. Seve & R. Jaussaud. (2020) Vogt-Koyanagi-Harada disease: a retrospective and multicentric study of 41 patients. BMC Ophthalmology 20:1.
Crossref
Andreas Reiff. (2020) Clinical Presentation, Management, and Long‐Term Outcome of Pars Planitis, Panuveitis, and Vogt‐Koyanagi‐Harada Disease in Children and Adolescents. Arthritis Care & Research 72:11, pages 1589-1596.
Crossref
Gerard Espinosa, José M. Herreras, Santiago Muñoz-Fernández, José M. García Ruiz de Morales & Miguel Cordero-Coma. (2020) Documento de recomendaciones sobre el tratamiento con inmunodepresores de la uveítis no anterior, no infecciosa, no neoplásica. Medicina Clínica 155:5, pages 220.e1-220.e12.
Crossref
Gerard Espinosa, José M. Herreras, Santiago Muñoz-Fernández, José M. García Ruiz de Morales & Miguel Cordero-Coma. (2020) Recommendations statement on the immunosuppressive treatment of non-infectious, non-neoplastic, non-anterior uveitis. Medicina Clínica (English Edition) 155:5, pages 220.e1-220.e12.
Crossref
Rui Chang, Lin Chen, Guannan Su, Liping Du, Yang Qin, Jing Xu, Handan Tan, Chunjiang Zhou, Qingfeng Cao, Gangxiang Yuan, Aize Kijlstra & Peizeng Yang. (2020) Identification of Ribosomal Protein S4, Y-Linked 1 as a cyclosporin A plus corticosteroid resistance gene. Journal of Autoimmunity 112, pages 102465.
Crossref
Hasenin Al-khersan, Nimesh A. Patel & Thomas A. Albini. (2020) Rapidly Progressive Bilateral Visual Acuity Loss in a Middle-Aged Woman. JAMA Ophthalmology 138:6, pages 706.
Crossref
Juan Alberto Paz-Solarte, Marisa Hernández-Garfella, Amalia Rueda-Cid, Cristina Campos-Fernández & Javier Calvo-Catala. (2020) Rare association between Vogt–Koyanagi–Harada disease and rheumatoid arthritis: Report of a clinical case from the unit of multidisciplinary uveitis. Reumatología Clínica (English Edition) 16:1, pages 59-61.
Crossref
Juan Alberto Paz-Solarte, Marisa Hernández-Garfella, Amalia Rueda-Cid, Cristina Campos-Fernández & Javier Calvo-Catala. (2020) Rara asociación entre la enfermedad de Vogt-Koyanagi-Harada y la artritis reumatoide. Reporte de un caso clínico de la consulta multidisciplinar de uveítis. Reumatología Clínica 16:1, pages 59-61.
Crossref
H. Nida Sen. 2020. Whitcup and Nussenblatt's Uveitis. Whitcup and Nussenblatt's Uveitis
296
309
.
Akshay S. Thomas. 2020. Uveitis. Uveitis
43
99
.
Mamoona Sultan, Adeena Khan, Syed Shahid Habib & Dheyab Abdulsalam. (2019) Unique clinical spectrum with distinguishing diagnostic features in Vogt-Koyanagi-Harada syndrome. BMJ Case Reports 12:12, pages e231397.
Crossref
Carl P. HerbortJr.Jr., Ahmed M. Abu El Asrar, Masuru Takeuchi, Carlos E. Pavésio, Cristobal Couto, Alireza Hedayatfar, Kazuichi Maruyama, Xi Rao, Sukhum Silpa-archa & Thanapong Somkijrungroj. (2018) Catching the therapeutic window of opportunity in early initial-onset Vogt–Koyanagi–Harada uveitis can cure the disease. International Ophthalmology 39:6, pages 1419-1425.
Crossref
Cristhian A. Urzua. 2019. Advances in the Diagnosis and Management of Uveitis. Advances in the Diagnosis and Management of Uveitis.
Makiko Nakayama, Hiroshi Keino, Takayo Watanabe & Annabelle A Okada. (2019) Clinical features and visual outcomes of 111 patients with new-onset acute Vogt-Koyanagi-Harada disease treated with pulse intravenous corticosteroids. British Journal of Ophthalmology 103:2, pages 274-278.
Crossref
Ji Soo KimDong Yoon KimKyung Tae KimJu Byung Chae. (2019) Clinical Features of Recurred Vogt-Koyanagi-Harada Syndrome during Oral Steroids Tapering Therapy. Journal of the Korean Ophthalmological Society 60:4, pages 331.
Crossref
Madhura A. Tamhankar. 2019. Liu, Volpe, and Galetta's Neuro-Ophthalmology. Liu, Volpe, and Galetta's Neuro-Ophthalmology
53
99
.
Chan Zhao, Fangtian Dong, Fei Gao, Xinshu Liu, Minghang Pei, Shanshan Jia & Meifen Zhang. (2018) Longitudinal observation of subretinal fibrosis in Vogt-Koyanagi-Harada disease. BMC Ophthalmology 18:1.
Crossref
Gustavo A. Budmann, Ludmila García Franco & Alejandra Pringe. (2018) Long term treatment with infliximab in pediatric Vogt-Koyanagi-Harada disease. American Journal of Ophthalmology Case Reports 11, pages 139-141.
Crossref
L.E. Concha-del Río, L. Gómez & L. Arellanes-García. (2018) Corticotherapy vs. corticotherapy plus immunosuppressive therapy in acute Vogt-Koyanagi-Harada disease. Archivos de la Sociedad Española de Oftalmología (English Edition) 93:5, pages 225-230.
Crossref
L.E. Concha-del Río, L. Gómez & L. Arellanes-García. (2018) Corticoterapia vs. corticoterapia con inmunosupresores en el tratamiento de la fase aguda del síndrome de Vogt-Koyanagi-Harada. Archivos de la Sociedad Española de Oftalmología 93:5, pages 225-230.
Crossref
Carl P. Herbort Jr, Ahmed M. Abu El Asrar, Joyce H. Yamamoto, Carlos E. Pavésio, Vishali Gupta, Moncef Khairallah, Ilknur Tugal-Tutkun, Masoud Soheilian, Masuru Takeuchi & Marina Papadia. (2016) Reappraisal of the management of Vogt–Koyanagi–Harada disease: sunset glow fundus is no more a fatality. International Ophthalmology 37:6, pages 1383-1395.
Crossref
Irfan Khan, Ashvini K. Reddy & Jennifer E. Thorne. (2017) Systemic Treatment for Noninfectious Intraocular Inflammation. Current Ophthalmology Reports 5:1, pages 98-105.
Crossref
Ahmed M. Abu El-Asrar, Mona Dosari, Suhail Hemachandran, Priscilla W. Gikandi & Abdulrahman Al-Muammar. (2017) Mycophenolate mofetil combined with systemic corticosteroids prevents progression to chronic recurrent inflammation and development of ‘sunset glow fundus’ in initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease. Acta Ophthalmologica 95:1, pages 85-90.
Crossref
Ghazala A. Datoo O'Keefe & Narsing A. Rao. (2017) Vogt-Koyanagi-Harada disease. Survey of Ophthalmology 62:1, pages 1-25.
Crossref
Nora W. Muakkassa & Andre J. Witkin. 2017. Choroidal Disorders. Choroidal Disorders
185
198
.
Marcelo Mendes Lavezzo, Viviane Mayumi Sakata, Celso Morita, Ever Ernesto Caso Rodriguez, Smairah Frutuoso Abdallah, Felipe T. G. da Silva, Carlos Eduardo Hirata & Joyce Hisae Yamamoto. (2016) Vogt-Koyanagi-Harada disease: review of a rare autoimmune disease targeting antigens of melanocytes. Orphanet Journal of Rare Diseases 11:1.
Crossref
Sukhum Silpa-archa, Narumol Silpa-archa, Janine M. Preble & C. Stephen Foster. (2016) Vogt–Koyanagi–Harada syndrome: Perspectives for immunogenetics, multimodal imaging, and therapeutic options. Autoimmunity Reviews 15:8, pages 809-819.
Crossref
Elizabeth Shen, Sivakumar R. Rathinam, Manohar Babu, Anuradha Kanakath, Radhika Thundikandy, Salena M. Lee, Erica N. Browne, Travis C. Porco & Nisha R. Acharya. (2016) Outcomes of Vogt-Koyanagi-Harada Disease: A Subanalysis From a Randomized Clinical Trial of Antimetabolite Therapies. American Journal of Ophthalmology 168, pages 279-286.
Crossref
Liping Du, Aize Kijlstra & Peizeng Yang. (2016) Vogt-Koyanagi-Harada disease: Novel insights into pathophysiology, diagnosis and treatment. Progress in Retinal and Eye Research 52, pages 84-111.
Crossref
Karolyn A. Wanat, Benjamin Kim & Misha Rosenbach. (2016) Multisystem diseases affecting the skin and eye. Clinics in Dermatology 34:2, pages 214-241.
Crossref
Nidhi Relhan, Harry W. FlynnJr.Jr. & Thomas A. Albini. 2016. Manual of Retinal Diseases. Manual of Retinal Diseases
263
268
.
Arminda Neves, Ana Cardoso, Mariana Almeida, Joana Campos, António Campos & João Paulo Castro Sousa. (2015) Unilateral Vogt-Koyanagi-Harada Disease: A Clinical Case Report. Case Reports in Ophthalmology 6:3, pages 361-365.
Crossref
Cristhian A. Urzua, Victor Velasquez, Pablo Sabat, Osvaldo Berger, Sebastian Ramirez, Annelise Goecke, Darío H. Vásquez, Hector Gatica & Julia Guerrero. (2015) Earlier immunomodulatory treatment is associated with better visual outcomes in a subset of patients with Vogt-Koyanagi-Harada disease. Acta Ophthalmologica 93:6, pages e475-e480.
Crossref
Roham Soheilian. (2015) Uveítis en Enfermedades Sistémicas No-Infecciosas. Highlights of Vitreoretina 8:2, pages 7-13.
Crossref
Viviane Mayumi Sakata, Felipe Theodoro da Silva, Carlos Eduardo Hirata, Jozélio Freire de Carvalho & Joyce Hisae Yamamoto. (2014) Diagnosis and classification of Vogt–Koyanagi–Harada disease. Autoimmunity Reviews 13:4-5, pages 550-555.
Crossref
Michele Reibaldi, Andrea Russo, Teresio Avitabile, Maurizio G. Uva, Livio Franco, Antonio Longo, Mario D. Toro, Gilda Cennamo, Cesare Mariotti, Piergiorgio Neri, Nicola D. Noci & Vincenzo Russo. (2014) TREATMENT OF PERSISTENT SEROUS RETINAL DETACHMENT IN VOGT–KOYANAGI–HARADA SYNDROME WITH INTRAVITREAL BEVACIZUMAB DURING THE SYSTEMIC STEROID TREATMENT. Retina 34:3, pages 490-496.
Crossref
Piergiorgio Neri, Ilir Arapi, Uwe Pleyer, Moncef Khairallah, Soumyava Basu, Michele Nicolai, Vittorio Pirani, Alfonso Giovannini & Cesare Mariotti. 2014. Immune Modulation and Anti-Inflammatory Therapy in Ocular Disorders. Immune Modulation and Anti-Inflammatory Therapy in Ocular Disorders
161
218
.
Andreas Reiff, Sibel Kadayifcilar & Seza Özen. (2013) Rheumatic Inflammatory Eye Diseases of Childhood. Rheumatic Disease Clinics of North America 39:4, pages 801-832.
Crossref
Ahmed M. Abu El-Asrar, Mamdouh Al Tamimi, Suhail Hemachandran, Hani S. Al-Mezaine, Abdulrahman Al-Muammar & Dustan Kangave. (2013) Prognostic factors for clinical outcomes in patients with Vogt-Koyanagi-Harada disease treated with high-dose corticosteroids. Acta Ophthalmologica 91:6, pages e486-e493.
Crossref
Mili Roy. (2013) Vogt–Koyanagi–Harada disease: a forgotten entity in the Canadian uveitis landscape?. Canadian Journal of Ophthalmology 48:3, pages 133-135.
Crossref
David Ehmann, Matthew T.S. Tennant, Riz Somani & Chris J. Rudnisky. (2013) Vogt–Koyanagi–Harada disease in First Nations and Métis of Northern Alberta. Canadian Journal of Ophthalmology 48:3, pages 146-152.
Crossref
Maria de Lourdes Arellanes-García, Luz Elena Concha-del-Río, Maria del Carmen Preciado-Delgadillo & Claudia Recillas-Gipsert. 2013. Retinal and Choroidal Manifestations of Selected Systemic Diseases. Retinal and Choroidal Manifestations of Selected Systemic Diseases
353
376
.
Ahmed M. Abu El‐Asrar, Suhail Hemachandran, Hani S. Al‐Mezaine, Dustan Kangave & Abdulrahman M. Al‐Muammar. (2012) The outcomes of mycophenolate mofetil therapy combined with systemic corticosteroids in acute uveitis associated with Vogt–Koyanagi–Harada disease. Acta Ophthalmologica 90:8.
Crossref
Rosa Dolz-Marco, Roberto Gallego-Pinazo & Manuel Díaz-Llopis. (2011) Rituximab in refractory Vogt–Koyanagi–Harada disease. Journal of Ophthalmic Inflammation and Infection 1:4, pages 177-180.
Crossref
Marie-Hélène Errera, Christine Fardeau, David Cohen, Audrey Navarro, Alain Gaudric, Bahram Bodaghi, Mark Westcott & Phuc LeHoang. (2011) Effect of the duration of immunomodulatory therapy on the clinical features of recurrent episodes in Vogt-Koyanagi-Harada disease. Acta Ophthalmologica 89:4, pages e357-e366.
Crossref
Esperanza Pato, Santiago Muñoz-Fernández, Félix Francisco, Miguel A. Abad, Jesús Maese, Ana Ortiz & Loreto Carmona. (2011) Systematic Review on the Effectiveness of Immunosuppressants and Biological Therapies in the Treatment of Autoimmune Posterior Uveitis. Seminars in Arthritis and Rheumatism 40:4, pages 314-323.
Crossref
. 2011. Andrews' Diseases of the Skin. Andrews' Diseases of the Skin
846
862
.
Jonathan Lipps & Muhammad Asim Khan. (2010) Vogt–Koyanagi–Harada syndrome: a rheumatologic perspective. International Journal of Clinical Rheumatology 5:2, pages 255-263.
Crossref
Robert B. Nussenblatt. 2010. Uveitis. Uveitis
303
318
.
Grant T. Liu, Nicholas J. Volpe & Steven L. Galetta. 2010. Neuro-Ophthalmology. Neuro-Ophthalmology
55
101
.
Micheal J. Gallagher, Taygan Yilmaz & C. Stephen Foster. (2009) Vogt-Koyanagi-Harada Syndrome Associated With Bilateral Serous Macular Detachments Responsive to Immunomodulatory Therapy. Ophthalmic Surgery, Lasers and Imaging Retina 40:3, pages 345-347.
Crossref
Lourdes Arellanes García, Mónica Orozco Carroll & Manuel Alejandro Garza León. (2008) Vogt-Koyanagi-Harada Syndrome in Childhood. International Ophthalmology Clinics 48:3, pages 107-117.
Crossref
Moncef Khairallah, Sonia Zaouali, Riadh Messaoud, Sami Chaabane, Sonia Attia, Salim Ben Yahia & Kamel Hmidi. (2007) The spectrum of Vogt-Koyanagi-Harada disease in Tunisia, North Africa. International Ophthalmology 27:2-3, pages 125-130.
Crossref
Christopher M. Andreoli & C. Stephen Foster. (2006) Vogt-Koyanagi-Harada Disease. International Ophthalmology Clinics 46:2, pages 111-122.
Crossref